Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma, Malignant × Disulfides × Clear all

Sponsor

Conditions

Ovarian Neoplasms 14 Fallopian Tube Neoplasms 14 Glioblastoma 7 Lung Neoplasms 6 Carcinoma, Renal Cell 6 Carcinoma, Non-Small-Cell Lung 6 Brenner Tumor 6 Colorectal Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Melanoma 4 Gliosarcoma 4 Breast Neoplasms 4 Brain Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Recurrent Squamous Cell Lung Carcinoma 3 Oligodendroglioma 3 Spinal Cord Neoplasms 2 Prostatic Neoplasms 2 Medulloblastoma 2 Glioma 2 Colonic Neoplasms 2 Carcinoma 2 Astrocytoma 2 Adenocarcinoma of Lung 2 Vipoma 1 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1

Interventions

Pemetrexed 14 Cisplatin 13 pembrolizumab 4 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Radiotherapy 3 Gemcitabine 3 Carboplatin 3 cediranib 2 amatuximab 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Drug Therapy 2 Cyclophosphamide 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tremelimumab 1 sodium thiosulfate 1 sargramostim 1 nintedanib 1 napabucasin 1 methoxyamine 1 liposomal doxorubicin 1 incomplete Freund's adjuvant 1 fresolimumab 1 durvalumab 1 defactinib 1 cixutumumab 1 bintrafusp alfa protein, human 1 bemcentinib 1 belinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡